Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-07-21

Clinical Trial Update: Clinical Trial of CBS-2004 in Prevention of Travelers' Diarrhea [Phase 3]

View source ↗

Summary

Phase 3 trial CBS-2004 for prevention of traveler's diarrhea was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CBS-2004

Snippet

Sponsor: Clasado Biosciences Ltd | Conditions: Traveler's Diarrhea | Phase 3 | Status: WITHDRAWN